首页>
外国专利>
RECURRENT MUTATIONS IN EPIGENETIC REGULATORS, RHOA AND FYN KINASE IN PERIPHERAL T-CELL LYMPHOMAS
RECURRENT MUTATIONS IN EPIGENETIC REGULATORS, RHOA AND FYN KINASE IN PERIPHERAL T-CELL LYMPHOMAS
展开▼
机译:周围T细胞淋巴瘤中表观调节剂 RHOA I>和 FYN I>激酶的递归突变
展开▼
页面导航
摘要
著录项
相似文献
摘要
Whole exome sequencing of 12 tumor-normal DNA pairs, RNAseq analysis and targeted deep sequencing identified new genetic alterations in PTCL transformation. These analyses identified highly recurrent epigenetic factor mutations in TET2, DNMT3A and IDH2 as well as a new highly prevalent RHOA p.Gly17Val (NM_001664) mutation present in 22/35 (67%) of angioimmunoblastic T-cell lymphomas (AITL) and in 8/44 (18%) not otherwise specified PTCL (PTCL NOS) samples. Mechanistically, the RHOA Gly17Val protein interferes with RHOA signaling in biochemical and cellular assays, an effect potentially mediated by the sequestration of activated Guanine Exchange Factor (GEF) proteins. In addition, new and recurrent, genetic defects are described including mutations in FYN, ATM, B2M and CD58 implicating SRC signaling, impaired DNA damage response and escape from immune surveillance mechanisms in the pathogenesis of PTCL.
展开▼